HB 1043 amends Pennsylvania's Public School Code to expand access to emergency allergy and asthma treatments in schools. The bill specifically allows school staff, including bus drivers and crossing guards, to possess, use, and administer epinephrine auto-injectors (like EpiPens) and asthma inhalers for students in medical emergencies. It updates definitions and procedures to ensure authorized personnel can act quickly during allergic reactions or asthma attacks without requiring individual physician orders each time. This directly affects students with life-threatening allergies or asthma and school staff who may need to provide immediate care.
SB 715 extends the expiration date of Pennsylvania's Rare Disease Advisory Council from June 30, 2025, to June 30, 2028. This procedural bill directly affects the council, which advises state departments on rare disease issues, and the departments it collaborates with (Health, Insurance, Human Services, Education). The key provision simply changes the expiration date in the 2017 law without altering the council's structure or duties. This extension provides continued operation of the council for an additional three years.
SB 731 amends the existing Pharmaceutical Assistance Contract for the Elderly (PACE) program to add a new "Needs Enhancement Tier" for determining eligibility. This tier would allow more elderly residents to qualify for prescription drug assistance based on specific financial or health needs. The bill changes how eligibility is assessed under the program, making it easier for seniors with higher needs to access medication support. The bill recently passed final passage on November 12, 2025, and is now referred to Rules & Executive Nominations.
HB 416 establishes a new Child Care Staff Recruitment and Retention Program to support early childhood educators and creates a Rural Health Transformation Program to improve healthcare access in underserved areas. It also streamlines permit processes for economic development projects through the Streamlining Permits for Economic Expansion and Development Program. These provisions are integrated into the 2025 state budget implementation, alongside administrative updates to tax collection procedures, state fund management, and reporting requirements for agencies like the Department of Revenue and Treasury. The bill does not alter existing tax rates or create new funding streams but modifies how current state financial systems operate.
HB 749 updates Pennsylvania's public welfare laws to streamline assistance programs and improve service access. It requires copayments for subsidized child care, changes reporting for SNAP benefits, and mandates reports on transitioning to chip-enabled access cards for benefits. The bill removes regulatory barriers for outpatient behavioral health services provided within clinic facilities, allowing services to be billed as part of the clinic visit. It also requires additional reports to the General Assembly regarding medical assistance eligibility and nonemergency medical transportation services.
HB 446 requires hospitals and ambulatory surgical facilities in Pennsylvania to offer patients unused, facility-provided medication at no additional cost upon discharge, if the prescriber determines it's clinically appropriate for continuing treatment. The bill specifies that this applies only to non-controlled, multi-dose medications like eye drops, creams, or inhalers (excluding IV drugs or controlled substances), and mandates clear discharge instructions with usage details and contact information. Providers acting in good faith are protected from liability for patient misuse, and such medication offers are exempt from standard outpatient dispensing rules. This directly affects patients discharged from hospitals or ambulatory facilities and the healthcare facilities providing their care.
HB 1828 requires health insurance plans in Pennsylvania to cover all recommended vaccines without requiring patients to pay out-of-pocket costs like copays or deductibles. It directly affects insurance companies by mandating this coverage and patients who rely on insurance for routine immunizations (e.g., childhood vaccines, flu shots). The bill adds penalties for insurers that fail to comply with the coverage requirement. This policy change ensures broader access to vaccines by removing financial barriers under insurance plans.
HB 305 requires health insurance policies to cover insulin, directly affecting people with diabetes who rely on this medication. It amends the 1921 Insurance Company Law to mandate that casualty insurance plans include insulin coverage without excessive cost-sharing. The key provision eliminates gaps where insulin might previously have been excluded or subject to high out-of-pocket costs. This policy change applies to all insurers offering casualty coverage under the amended law. The bill is currently pending before the Insurance committee.
HB 157 creates state grants to help healthcare entities in rural counties or designated medically underserved areas cover the student loan debt of their employed healthcare practitioners. The grants would be paid directly to the healthcare facilities (like clinics or hospitals), not to individual providers, to offset the cost of practitioners' education debt. This aims to support recruitment and retention of healthcare workers in areas with limited access to medical services. The program would be funded through state appropriations, targeting facilities serving communities with significant healthcare access challenges.
HB 1212 requires Pennsylvania maternal health programs to provide drug screening and awareness education to patients. It also mandates the inclusion of fatherhood engagement strategies in prenatal care discussions, directly affecting pregnant individuals and their partners receiving maternal health services. The bill imposes specific duties on the Joint State Government Commission to develop and oversee these program requirements. These provisions aim to integrate substance use prevention and family involvement into standard maternal health care protocols.
